GLX351322
CAS No. 835598-94-2
GLX351322( —— )
Catalog No. M21200 CAS No. 835598-94-2
GLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 38 | Get Quote |
|
| 5MG | 61 | Get Quote |
|
| 10MG | 101 | Get Quote |
|
| 25MG | 230 | Get Quote |
|
| 50MG | 392 | Get Quote |
|
| 100MG | 582 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGLX351322
-
NoteResearch use only, not for human use.
-
Brief DescriptionGLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM.
-
DescriptionGLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM.
-
In VitroGLX351322 is an inhibitor of NADPH oxidase 4, and inhibits hydrogen peroxide production from NOX4-overexpressing cells with an IC50 of 5 μM. GLX351322 shows weak activity against NOX2 in hPBMC cells (IC50, 40 μM).
-
In VivoGLX351322 (3.8 mg/kg/day, p.o.) ameliorates HFD-induced hyperglycemia in mice.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetNADPH
-
RecptorNOX4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number835598-94-2
-
Formula Weight431.5
-
Molecular FormulaC21H25N3O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO:20 mg/mL (46.35 mM; Need ultrasonic)
-
SMILESCCOC(=O)c1c(NC(=O)CN2CCN(C(=O)c3ccco3)CC2)sc2c1CCC2
-
Chemical NameEthyl 2-[[2-[4-(furan-2-carbonyl)piperazin-1-yl]acetyl]amino]-56-dihydro-4H-cyclopenta-[b]thiophene-3-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Anvari Ebrahim Wikstr?m Per Walum Eriket al. The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice[J]. Free Radical Research 49(11):1-32.
molnova catalog
related products
-
Acetohexamide
Acetohexamide is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2.
-
gp91 ds-tat
gp91 ds-tat is a NADPH oxidase (NOX2) inhibitor that reduces NOX2 expression.
-
NoxA1ds
Potent and selective NADPH oxidase 1 (NOX1) inhibitor (IC50 = 20 nM). Exhibits selectivity for NOX1 over NOX2, NOX4, NOX5 and xanthine oxidase. Inhibits NOX1-derived O2- production in HT-29 human colon cancer cells. Attenuates VEGF-induced human pulmonary artery endothelial cell migration under hypoxic conditions in vitro. Cell permeable.
Cart
sales@molnova.com